Transcription activator-like effector nuclease
Part of a series on |
Genetic engineering |
---|
Genetically modified organisms |
History and regulation |
Process |
Applications |
Controversies |
Transcription activator-like effector nucleases (TALEN) are
TALE DNA-binding domain
DNA cleavage domain
The non-specific DNA cleavage domain from the end of the FokI endonuclease can be used to construct hybrid nucleases that are active in a yeast assay.[6][7] These reagents are also active in plant cells[8][9] and in animal cells.[9][10][11][12] Initial TALEN studies used the wild-type FokI cleavage domain, but some subsequent TALEN studies[11][13][14] also used FokI cleavage domain variants with mutations designed to improve cleavage specificity[15][16] and cleavage activity.[17] The FokI domain functions as a dimer, requiring two constructs with unique DNA binding domains for sites in the target genome with proper orientation and spacing. Both the number of amino acid residues between the TALE DNA binding domain and the FokI cleavage domain and the number of bases between the two individual TALEN binding sites appear to be important parameters for achieving high levels of activity.[10][18]
Engineering TALEN constructs
The simple relationship between amino acid sequence and DNA recognition of the TALE binding domain allows for the efficient engineering of proteins. In this case,
Transfection
Once the TALEN constructs have been assembled, they are inserted into plasmids; the target cells are then transfected with the plasmids, and the gene products are expressed and enter the nucleus to access the genome. Alternatively, TALEN constructs can be delivered to the cells as mRNAs, which removes the possibility of genomic integration of the TALEN-expressing protein. Using an mRNA vector can also dramatically increase the level of homology directed repair (HDR) and the success of introgression during gene editing.
Genome editing
Mechanisms
TALEN can be used to edit genomes by inducing double-strand breaks (DSB), which cells respond to with repair mechanisms.
Non-homologous end joining (NHEJ) directly ligates DNA from either side of a double-strand break where there is very little or no sequence overlap for annealing. This repair mechanism induces errors in the genome via indels (insertion or deletion), or chromosomal rearrangement; any such errors may render the gene products coded at that location non-functional.[10] Because this activity can vary depending on the species, cell type, target gene, and nuclease used, it should be monitored when designing new systems. A simple heteroduplex cleavage assay can be run which detects any difference between two alleles amplified by PCR. Cleavage products can be visualized on simple agarose gels or slab gel systems.
Alternatively, DNA can be introduced into a genome through NHEJ in the presence of exogenous double-stranded DNA fragments.[10]
Homology directed repair can also introduce foreign DNA at the DSB as the transfected double-stranded sequences are used as templates for the repair enzymes.[10]
Applications
TALEN has been used to efficiently modify plant genomes,
TALEN has also been utilized experimentally to correct the genetic errors that underlie disease.
In theory, the genome-wide specificity of engineered TALEN fusions allows for correction of errors at individual genetic loci via homology-directed repair from a correct exogenous template.[33] In reality, however, the in situ application of TALEN is currently limited by the lack of an efficient delivery mechanism, unknown immunogenic factors, and uncertainty in the specificity of TALEN binding.[33]
Another emerging application of TALEN is its ability to combine with other genome engineering tools, such as meganucleases. The DNA binding region of a TAL effector can be combined with the cleavage domain of a meganuclease to create a hybrid architecture combining the ease of engineering and highly specific DNA binding activity of a TAL effector with the low site frequency and specificity of a meganuclease.[39]
In comparison to other genome editing techniques, TALEN falls in the middle in terms of difficulty and cost. Unlike
TAL effector nuclease precision
The off-target activity of an active nuclease may lead to unwanted double-strand breaks and may consequently yield chromosomal rearrangements and/or cell death. Studies have been carried out to compare the relative nuclease-associated toxicity of available technologies. Based on these studies [18] and the maximal theoretical distance between DNA binding and nuclease activity, TALEN constructs are believed to have the greatest precision of the currently available technologies.[41]
See also
- Genome editing with engineered nucleases
- Zinc finger nuclease
- Meganuclease
- CRISPR
References
- ^ S2CID 304571.
- PMID 19400638.
- S2CID 206522347.
- S2CID 6648530.
- PMID 25632877.
- PMID 20660643.
- PMID 20699274.
- PMID 21262818.
- ^ PMID 21493687.
- ^ S2CID 53549397.
- ^ PMID 21738127.
- ^ PMID 21700836.
- ^ PMID 21822240.
- ^ S2CID 28802632.
- S2CID 14334237.
- S2CID 22079561.
- PMID 20447404.
- ^ PMID 21813459.
- ^ PMID 21248753.
- PMID 22328436.
- PMID 21421566.
- PMID 21459844.
- PMID 21625585.
- PMID 21625552.
- PMID 23124327.
- PMID 24851712.
- PMID 24871200.
- ^ PMID 25971621.
- PMID 23555929.
- PMID 21822241.
- PMID 25733846.
- PMID 24523878.
- ^ PMID 23344620.
- PMID 25245091.
- PMID 24236034.
- PMID 23546300.
- PMID 26061646.
- PMID 26183927.
- PMID 24285304.
- ^ "Pros and Cons Of ZFNS, TALENS, AND CRISPR/CAS". The Jackson Laboratory. March 2014.
- ^ Boglioli, Elsy; Richard, Magali. "Boston Consulting Group - Report on Gene Editing Precision" (PDF).
External links
- E-TALEN.org A comprehensive tool for TALEN design
- PDB Molecule of the Month An entry in the Protein Database's monthly structural highlight